Browse

Urinary Neutrophil Gelatinase-Associated Lipocalin as a Predictive Biomarker for the Progression of Renal Injury in Liver Transplant Recipients using Calcineurin Inhibitors
간이식 후 칼시뉴린 억제제 복용환자에서 신손상 예측 인자로서의 소변 Neutrophil Gelatinase-Associated Lipocalin(NGAL)의 유용성

Cited 0 time in Web of Science Cited 0 time in Scopus
Authors
윤경철
Advisor
이광웅
Major
의과대학 의학과
Issue Date
2017-02
Publisher
서울대학교 대학원
Keywords
Renal impairmentImmunosuppressantsNGALLiver transplant
Description
학위논문 (석사)-- 서울대학교 대학원 : 의학과, 2017. 2. 이광웅.
Abstract
Introduction: Calcineurin inhibitors (CNI) are commonly used in liver transplant (LT) recipients, though a known side effect is nephrotoxicity. Neutrophil gelatinase-associated lipocalin (NGAL) is a marker that is expressed in the kidneys after renal ischemia. We sought to evaluate the feasibility of NGAL as an early predictor of renal impairment in patients under CNI therapy.
Methods: Urine samples were obtained cross-sectionally from LT patients who visited the outpatient clinic from February 2016 to June 2016. Glomerular filtration rate (GFR) at the time of urine sampling was compared with that at 5-7 months later. Patients were divided into 3 groups according to the GFR at the time of urine sampling and the severity of renal dysfunction (Normal [GFR: > 90 mL/min/1.73 m2], Mild [GFR: 60-89 mL/min/1.73 m2], Moderate [GFR: 30-59 mL/min/1.73 m2]). They were then further divided into 2 groups according to urinary NGAL level (NGAL-High [urinary NGAL > 25 ng/mL], NGAL-Low [urinary NGAL < 25 ng/mL]). Progression of renal injury was defined as a decrease in GFR greater than 5 mL/min/1.73 m2 in the Mild or Moderate groups, or if the patient was shifted to either the Mild or Moderate group from the Normal group during the follow-up period.
Results: Fifty-one patients were enrolled in this study. Mean NGAL level was higher in the Moderate group than in the Normal and Mild groups (18.38 ± 14.31 vs. 7.74 ± 8.13, p < 0.01). A proportion of NGAL-High was also significantly higher in the Moderate group than in the Mild group (40% vs. 5%, p = 0.03). In the Mild and Moderate groups, NGAL-High was shown to be a significant risk factor for Progression of renal injury after follow-up by multivariate analysis (hazard ratio: 72.44
confidence interval : 1.283-4088.25), p=0.04).
Conclusion: Increased NGAL can be a marker of low GFR, as well as a predictor of renal injury after short-term follow-up in patients with mild to moderate renal impairment.
Language
English
URI
https://hdl.handle.net/10371/132941
Files in This Item:
Appears in Collections:
College of Medicine/School of Medicine (의과대학/대학원)Dept. of Medicine (의학과)Theses (Master's Degree_의학과)
  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse